Meet Slynd: A Novel Progestin-Only Pill

What’s this new pill? Slynd® is the new progestin-only oral contraceptive approved by the FDA in May 2019. This novel progestin-only pill (POP) contains drospirenone 4 mg in each active tablet, which is a higher dose than what is found in drospirenone-containing combined oral contraceptives (COCs).  Table 1. Products with drospirenone. Product Name Medication Doses…

Read More